Karen J. Wilson's Insider Trades & SAST Disclosures

Karen J. Wilson's most recent trade in Elicio Therapeutics Inc. was a trade of 7,900 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 19, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Elicio Therapeutics Inc.
Karen J. Wilson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 May 2025 7,900 7,900 - - Stock Option (Right to Buy)
LAVA Therapeutics NV
Karen J. Wilson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2025 33,390 33,390 - - Common Shares (Right to Buy)
Elicio Therapeutics Inc.
Karen J. Wilson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Nov 2024 4,100 4,100 - - Stock Option (Right to Buy)
Vaxart Inc
Karen J. Wilson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2021 15,097 15,097 - - Stock Option (right to buy)
Vaxart Inc
Karen J. Wilson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Aug 2020 65,700 65,700 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades